📰 Clinical Trials Program News
Page 3 - Clinical Trials Program News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Clinical Trials Program. Real-time updates on events, politics, business and more.
January 6, 2023
THURSDAY, Jan. 5, 2023 (HealthDay News) -- Lecanemab: Its an experimental medication thats been shown in trials to slow cognitive decline in people with Alzheimer’s disease.
January 6, 2023
FRIDAY, Jan. 6, 2023 (HealthDay News) -- The U.S. Food and Drug Administration on Friday approved a second Alzheimers drug, lecanemab, despite reports of rare brain bleeds linked to use
January 6, 2023
FRIDAY, Jan. 6, 2023 (HealthDay News) -- The U.S. Food and Drug Administration on Friday approved a second Alzheimers drug, lecanemab, despite reports of rare brain bleeds linked to use
January 5, 2023
THURSDAY, Jan. 5, 2023 (HealthDay News) -- Lecanemab: It’s an experimental medication that’s been shown in trials to slow cognitive decline in people with Alzheimer’s disease.
January 5, 2023
THURSDAY, Jan. 5, 2023 (HealthDay News) -- Lecanemab: Its an experimental medication thats been shown in trials to slow cognitive decline in people with Alzheimer’s disease.
January 5, 2023
THURSDAY, Jan. 5, 2023 (HealthDay News) -- Lecanemab: Its an experimental medication thats been shown in trials to slow cognitive decline in people with Alzheimer’s disease.
January 5, 2023
THURSDAY, Jan. 5, 2023 (HealthDay News) -- Lecanemab: Its an experimental medication thats been shown in trials to slow cognitive decline in people with Alzheimer’s disease.
November 15, 2022
The Lupus Research Alliance and its affiliate Lupus Therapeutics presented data at ACR Convergence 2022 with results showing the effectiveness of a pilot peer education program called the Patient Advocates for Lupus Studies (PALS), in increasing knowledge, perception, and willingness among people with Systemic Lupus Erythematosus (SLE) to participate in clinical trials.
November 8, 2022
/PRNewswire/ -- The Lupus Research Alliance and its affiliate Lupus Therapeutics will present data at ACR Convergence 2022 with results showing the...
August 12, 2022
The three-month virtual UH certificate program will prepare individuals for a thriving career in clinical research to better serve Hawaiʻi’s cancer patients.